)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Acrivon Therapeutics
Acrivon Therapeutics (ACRV) investor relations material
Acrivon Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary30 Apr, 2026
Executive summary
Annual meeting scheduled for June 17, 2026, to be held virtually for stockholders of record as of April 23, 2026.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request by June 5, 2026.
Voting matters and shareholder proposals
Election of two Class I directors: Michael Tomsicek, M.B.A., and Charles Baum, M.D., Ph.D.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Consideration of other business that may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and FOR the ratification of the auditor.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Acrivon Therapeutics
- Virtual meeting to elect directors and ratify auditor, with strong governance and oversight.ACRV
Proxy filing30 Apr 2026 - ACR-368 delivers high response rates and safety in serous endometrial cancer, surpassing current options.ACRVEuropean Society of Gynecological Oncology (ESGO) Congress 20269 Apr 2026
- 52% response rate in serous endometrial cancer and robust cash reserves support ongoing growth.ACRVQ4 202519 Mar 2026
- ACR-368 demonstrates high efficacy and safety in serous endometrial cancer, with rapid global trial expansion.ACRVTD Cowen 46th Annual Health Care Conference5 Mar 2026
- 62.5–63% response rate in biomarker-selected endometrial cancer with durable benefit.ACRVStudy Update20 Jan 2026
- ACR368 achieves a 63% response rate in biomarker-positive endometrial cancer, surpassing benchmarks.ACRV2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- ACR-368 achieves up to 67% response in serous endometrial cancer; ACR-6840 advances.ACRVStudy Update8 Jan 2026
- Virtual meeting to elect directors, ratify auditor, and review governance and compensation.ACRVProxy Filing2 Dec 2025
- Virtual meeting to elect directors and ratify auditor, with board support for all proposals.ACRVProxy Filing2 Dec 2025
Next Acrivon Therapeutics earnings date
Q1 20268 May, 2026
Acrivon Therapeutics
Next Acrivon Therapeutics earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage